What is AgaMatrix?
Founded in 2001 and headquartered in Salem, New Hampshire, AgaMatrix specializes in creating advanced diagnostic technologies for blood glucose monitoring. The company's product suite integrates mobile and cloud platforms, offering comprehensive data management solutions for individuals managing diabetes. This strategic focus positions AgaMatrix at the intersection of healthcare technology and personal wellness, aiming to enhance patient adherence and provide actionable insights through connected devices.
How much funding has AgaMatrix raised?
AgaMatrix has raised a total of $63.7M across 5 funding rounds:
Series A
$2.7M
Series B
$5M
Series C
$23.7M
Debt
$32M
Debt
$350K
Series A (2003): $2.7M with participation from Tank Partners and Collaborative Fund
Series B (2007): $5M, investors not publicly disclosed
Series C (2008): $23.7M supported by Noble International Ltd
Debt (2017): $32M featuring Prospect Capital Corporation
Debt (2020): $350K backed by PPP
Key Investors in AgaMatrix
Tank Partners
Tank Partners is an investment firm that has participated in AgaMatrix's early-stage funding rounds.
Collaborative Fund
Collaborative Fund is an investment entity that has backed AgaMatrix's initial development and expansion efforts.
Prospect Capital Corporation
Prospect Capital Corporation is a private equity firm that provided debt financing to AgaMatrix, indicating a focus on supporting established companies with growth capital.
What's next for AgaMatrix?
The substantial enterprise-level backing, including significant debt financing rounds, suggests AgaMatrix is in a mature phase of its growth, likely focusing on scaling its existing operations, expanding its market reach, and further developing its data management capabilities. The company's continued investment in mobile and cloud platforms indicates a commitment to leveraging digital health trends to improve diabetes care. Future strategic moves may involve partnerships or acquisitions to enhance its technological portfolio or distribution channels, solidifying its position in the competitive diagnostic technology market.
See full AgaMatrix company page
